Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Other Long Term Assets : ¥1,762 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Other Long Term Assets?

Tianjin Pharmaceutical Da Ren Tang Group's other long-term assets for the quarter that ended in Mar. 2024 was ¥1,762 Mil.

Tianjin Pharmaceutical Da Ren Tang Group's quarterly other long-term assets increased from Sep. 2023 (¥1,728 Mil) to Dec. 2023 (¥1,840 Mil) but then stayed the same from Dec. 2023 (¥1,840 Mil) to Mar. 2024 (¥1,762 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual other long-term assets increased from Dec. 2021 (¥953 Mil) to Dec. 2022 (¥1,070 Mil) and increased from Dec. 2022 (¥1,070 Mil) to Dec. 2023 (¥1,840 Mil).

Tianjin Pharmaceutical Da Ren Tang Group Other Long Term Assets Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Other Long Term Assets Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

1,165.46

1,016.10

952.86

1,070.13

1,840.18

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															1,087.89	1,711.23	1,728.04	1,840.18	1,762.45

Tianjin Pharmaceutical Da Ren Tang Group Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Other Long Term Assets

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines